Delivery Order SPE2DB22D2206-SPE2DB24FFB35

Award Date 1/11/24
Potential Completion Date 1/12/24
Potential Value $5.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $2,369.88, is for the delivery of Risperidone 0.5 mg tablets and is a Firm Fixed Price agreement. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Risperidone 0.5 mg tablets in 500-count bottles. The $1,276.62 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Risperidone 2 mg tablets. The contract has a ceiling value of $7,756.45 and an ultimate completion date of May 8, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,384,072 units of Risperidone 1 mg tablets in 500-count packages. The firm-fixed-price delivery order has a ceiling value of $1,852.66 and a completion date of November 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a firm fixed price delivery order for Risperidone 2 mg tablets to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a ceiling value of $2,005.50 and a performance period through April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. The award is associated with a larger indefinite delivery contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,718.57 delivery order is for the supply of Risperidone 0.25 mg tablets to support military and government healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is for the delivery of Risperidone 0.25 mg tablets, a medication used to treat mental health conditions. The total ceiling value of the contract is $5,757.42, and it is a Firm Fixed Price Delivery Order that will be completed by May 3, 2023. The contract does not have a set-aside designation, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,356.24 firm fixed-price delivery order is for the supply of Risperidone 0.5 mg tablets, a mental health medication. The contract has an ultimate completion date of August 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,557,139,467 tablets of the medication Risperidone 0.5 mg. The contract, valued at $3,428.60, is a Firm Fixed Price Delivery Order with a completion date of May 9, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. This award is part of a larger Indefinite...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Risperidone 2 mg tablets to the Defense Logistics Agency (DLA). The $3,333.72 firm fixed-price delivery order has a period of performance through July 15, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FFB35
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Risperidone 2 mg tablets. The contract has a ceiling value of $5,546.16 and an ultimate completion date of January 12, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 5/13/25, 9:56 AM